Chagas disease

Disease Description (Causes and Symptoms)

• Cause: Infection with the flagellated protozoan Trypanosoma cruzi, mainly transmitted by kissing bugs of the Reduviidae family (blood-sucking insects). It can also be transmitted through blood transfusion, organ transplantation, contaminated food, and congenital infection (transplacental transmission).
• Pathophysiology: During the acute phase, the parasite invades the blood and tissues, causing local inflammation and systemic symptoms. Subsequently, in some patients, chronic inflammation caused by the parasite and the host immune response leads to progressive damage in the heart (myocarditis, arrhythmias, heart failure) and gastrointestinal tract (megacolon and anorexia), among other areas. Chronic heart disease may develop decades after infection.
• Main symptoms: During the acute phase (incubation period: 1–2 weeks), localized swelling at the bite site, swelling around the eye (Romaña sign; unilateral periorbital swelling), fever, and enlarged lymph nodes may occur, although asymptomatic cases are also common. During the chronic phase, cardiovascular symptoms such as arrhythmias, heart failure, and cardiomegaly, as well as, rarely, gastrointestinal dilation, may occur.

Treatment Methods

• Parasite-specific treatment (curative treatment)
  • Recommended medications (the treating physician determines the standard treatment according to the region and clinical status):
    • Benznidazole: standard oral regimen (e.g., 5 mg/kg for 60 days) — (based on the information provided).
    • Nifurtimox: based on the information provided, adults receive 8–10 mg/kg and children 15–20 mg/kg orally for 90–120 days.
  • Treatment response varies depending on age and disease stage, and the treatment success rate in adults varies among reports (information provided: approximately 70% treatment efficacy in adults).
  • Blood tests and monitoring of liver and kidney function are required before and during treatment (for management of medication side effects).
• Treatment of chronic complications (symptom and complication management)
  • Cardiac complications: pharmacological treatment of heart failure (ACE inhibitors/ARBs, beta-blockers, diuretics, etc.); antiarrhythmic drugs, an implantable cardioverter-defibrillator (ICD), or a pacemaker may be considered for arrhythmias; heart transplantation may be considered in end-stage heart failure.
  • Gastrointestinal complications: dietary, endoscopic, and surgical treatment (in cases of severe megacolon and anorexia), etc.
• Lifestyle management and precautions
  • Immediate medical attention is required if hepatic, renal, or hematologic abnormalities (such as anemia or leukopenia) are observed while taking the medication.
  • Treatment of special populations, including pregnant or breastfeeding individuals and children, requires review and specialist judgment.
• Prevention and public health
  • Vector control, improvement of housing conditions, screening of blood and organ donors, food safety, and screening of pregnant women are important.

Outpatient Visit Checklist (Including Preparation Items and Example Questions)

• Preparation items (before the appointment)
  • List of currently used medications (including prescriptions, OTC medications, and herbal medicines)
  • Previous medical certificates and test results (such as blood tests and electrocardiogram/echocardiogram results), or copies if possible
  • The onset and course of current symptoms (fever, swelling, palpitations, shortness of breath, etc.) and records related to symptom worsening or improvement
  • Travel history (whether and when you stayed in Latin America), history of transfusion or transplantation, and pregnancy status
• Information helpful to provide to the doctor during the outpatient visit
  • Recent weight changes, decline in daily functioning, and any fainting or fainting-like symptoms
  • Presence or absence of cardiac symptoms (shortness of breath, paroxysmal nocturnal dyspnea, swelling of the lower extremities) and gastrointestinal symptoms (difficulty swallowing, constipation, and abdominal bloating)

Examples of General Questions to Ask the Doctor

• What are the expected effects and common side effects of this medication?
• How long will treatment last, and what follow-up tests will be needed after treatment?
• Chronic cardiac complications are already suspected; what additional tests should I undergo?
• If I am pregnant or planning to become pregnant, how should treatment or screening be managed?
• What should I be careful about in daily life, and what is the long-term prognosis?

Examples of Disease-Specific Questions

• What preventive and monitoring measures are needed to reduce the risk of progression of chronic-phase cardiac complications (arrhythmias and heart failure)?
• If infection is suspected during pregnancy, how are testing and management for congenital infection in the fetus carried out (including treatment recommendations)?

Additional Information (Summary of Diagnostic Methods, Prognosis, and Complications)

• Diagnosis: During the acute phase, concentrating the blood and observing the protozoa under a microscope is useful; during the chronic phase, serologic tests (antibody tests) and PCR (detection of protozoal DNA) are used.
• Complications: Chronic heart disease (arrhythmias, heart failure, cardiomegaly), gastrointestinal enlargement (megaesophagus and megacolon), and, rarely, fatal complications.
• Prognosis: Many patients remain asymptomatic with chronic infection, but approximately 20–30% may develop severe cardiac or gastrointestinal complications years to decades later, and children with acute infection have a higher risk of death than adults.

(The information above may vary depending on the clinical situation and regional guidelines, so please consult the treating specialist regarding specific testing and treatment plans.)